Filtros de búsqueda

Lista de obras de Elisabeth Rexen Ulven

A protocol for amide bond formation with electron deficient amines and sterically hindered substrates

artículo científico publicado en 2016

Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases

artículo científico publicado en 2015

Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.

artículo científico publicado en 2012

Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40.

artículo científico publicado en 2011

Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.

artículo científico publicado en 2016

Dihydropyridine Fluorophores Allow for Specific Detection of Human Antibodies in Serum.

artículo científico publicado en 2018

Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties

scientific article published on 12 October 2018

Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties.

artículo científico publicado en 2011

Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity

artículo científico publicado en 2016

Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91.

artículo científico publicado en 2017

Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1.

artículo científico publicado en 2018

Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators

scientific article published on 19 March 2020

Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.

artículo científico publicado en 2010

The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda